Literature DB >> 19933380

Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs).

Terry W Moore1, Christopher G Mayne, John A Katzenellenbogen.   

Abstract

Because of their central importance in gene regulation and mediating the actions of many hormones, the nuclear receptors (NRs) have long been recognized as very important biological and pharmaceutical targets. Of all the surfaces available on a given NR, the singular site for regulation of receptor activity has almost invariably been the ligand-binding pocket of the receptor, the site where agonists, antagonists, and selective NR modulators interact. With our increasing understanding of the multiple molecular components involved in NR action, researchers have recently begun to look to additional interaction sites on NRs for regulating their activities by novel mechanisms. The alternate NR-associated interaction sites that have been targeted include the coactivator-binding groove and allosteric sites in the ligand-binding domain, the zinc fingers of the DNA-binding domain, and the NR response element in DNA. The studies thus far have been performed with the estrogen receptors, the androgen receptor (AR), the thyroid hormone receptors, and the pregnane X receptor. Phenotypic and conformation-based screens have also identified small molecule modulators that are believed to function through the NRs but have, as yet, unknown sites and mechanisms of action. The rewards from investigation of these NR alternate-site modulators should be the discovery of new therapeutic approaches and novel agents for regulating the activities of these important NR proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933380      PMCID: PMC2852352          DOI: 10.1210/me.2009-0362

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  113 in total

1.  An inhibitor of the interaction of thyroid hormone receptor beta and glucocorticoid interacting protein 1.

Authors:  T R Geistlinger; R K Guy
Journal:  J Am Chem Soc       Date:  2001-02-21       Impact factor: 15.419

Review 2.  Recognition of the DNA minor groove by pyrrole-imidazole polyamides.

Authors:  Peter B Dervan; Benjamin S Edelson
Journal:  Curr Opin Struct Biol       Date:  2003-06       Impact factor: 6.809

3.  Solid-phase synthesis of disulfide heterodimers of peptides.

Authors:  Amit K Galande; Arno F Spatola
Journal:  Org Lett       Date:  2003-09-18       Impact factor: 6.005

4.  Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment.

Authors:  Ngoc-Ha Nguyen; James W Apriletti; Suzana T Cunha Lima; Paul Webb; John D Baxter; Thomas S Scanlan
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

5.  Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists.

Authors:  Huey-Jing Huang; John D Norris; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2002-08

6.  Novel selective inhibitors of the interaction of individual nuclear hormone receptors with a mutually shared steroid receptor coactivator 2.

Authors:  Timothy R Geistlinger; R Kiplin Guy
Journal:  J Am Chem Soc       Date:  2003-06-11       Impact factor: 15.419

7.  Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics.

Authors:  Akira Takeshita; Manabu Taguchi; Noriyuki Koibuchi; Yasunori Ozawa
Journal:  J Biol Chem       Date:  2002-06-18       Impact factor: 5.157

Review 8.  Phytoestrogens: recent developments.

Authors:  Paul Cos; Tess De Bruyne; Sandra Apers; Dirk Vanden Berghe; Luc Pieters; Arnold J Vlietinck
Journal:  Planta Med       Date:  2003-07       Impact factor: 3.352

9.  Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator.

Authors:  Kazuo Nishimura; Huei-Ju Ting; Yasunori Harada; Takashi Tokizane; Norio Nonomura; Hong-Yo Kang; Hong-Chiang Chang; Shuyuan Yeh; Hiroshi Miyamoto; Masaru Shin; Katsuyuki Aozasa; Akihiko Okuyama; Chawnshang Chang
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

10.  Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription.

Authors:  J Wesley Pike; Peterman Pathrose; Olga Barmina; Ching-Yi Chang; Donald P McDonnell; Hironori Yamamoto; Nirupama K Shevde
Journal:  J Cell Biochem       Date:  2003-02-01       Impact factor: 4.429

View more
  47 in total

Review 1.  The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer.

Authors:  Donald P McDonnell; Suzanne E Wardell
Journal:  Curr Opin Pharmacol       Date:  2010-12       Impact factor: 5.547

2.  Research resource: modulators of glucocorticoid receptor activity identified by a new high-throughput screening assay.

Authors:  John A Blackford; Kyle R Brimacombe; Edward J Dougherty; Madhumita Pradhan; Min Shen; Zhuyin Li; Douglas S Auld; Carson C Chow; Christopher P Austin; S Stoney Simons
Journal:  Mol Endocrinol       Date:  2014-05-21

Review 3.  Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain.

Authors:  N G R Dayan Elshan; Matthew B Rettig; Michael E Jung
Journal:  Med Res Rev       Date:  2018-11-22       Impact factor: 12.944

4.  Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-α.

Authors:  Yongxian Ma; York Tomita; Anju Preet; Robert Clarke; Erikah Englund; Scott Grindrod; Shyam Nathan; Eliseu De Oliveira; Milton L Brown; Eliot M Rosen
Journal:  Mol Endocrinol       Date:  2014-12

Review 5.  Steroid receptor/coactivator binding inhibitors: An update.

Authors:  Kornelia J Skowron; Kenneth Booker; Changfeng Cheng; Simone Creed; Brian P David; Phillip R Lazzara; Amy Lian; Zamia Siddiqui; Thomas E Speltz; Terry W Moore
Journal:  Mol Cell Endocrinol       Date:  2019-06-01       Impact factor: 4.102

6.  Modification of the Orthosteric PPARγ Covalent Antagonist Scaffold Yields an Improved Dual-Site Allosteric Inhibitor.

Authors:  Richard Brust; Hua Lin; Jakob Fuhrmann; Alice Asteian; Theodore M Kamenecka; Douglas J Kojetin
Journal:  ACS Chem Biol       Date:  2017-02-16       Impact factor: 5.100

7.  In search of novel drug target sites on estrogen receptors using RNA aptamers.

Authors:  Daiying Xu; Vamsee-Krishna Chatakonda; Antonis Kourtidis; Douglas S Conklin; Hua Shi
Journal:  Nucleic Acid Ther       Date:  2014-03-03       Impact factor: 5.486

Review 8.  Targeting truncated RXRα for cancer therapy.

Authors:  Xiaokun Zhang; Hu Zhou; Ying Su
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-10-21       Impact factor: 3.848

9.  Novel yeast-based strategy unveils antagonist binding regions on the nuclear xenobiotic receptor PXR.

Authors:  Hao Li; Matthew R Redinbo; Madhukumar Venkatesh; Sean Ekins; Anik Chaudhry; Nicolin Bloch; Abdissa Negassa; Paromita Mukherjee; Ganjam Kalpana; Sridhar Mani
Journal:  J Biol Chem       Date:  2013-03-22       Impact factor: 5.157

10.  Structural basis for cyclic Py-Im polyamide allosteric inhibition of nuclear receptor binding.

Authors:  David M Chenoweth; Peter B Dervan
Journal:  J Am Chem Soc       Date:  2010-10-20       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.